Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms
Authors:
- Ana RicheliaARAna Richelia
- Meenakshi AkhileshMAMeenakshi Akhilesh
- Aye Aye ThikeATAye Aye Thike
- Philip Chi‐Wai LuiPLPhilip Chi‐Wai Lui
- Gary Man‐Kit TseGTGary Man‐Kit Tse
- Puay Hoon TanPTPuay Hoon Tan
- 19 August 2010
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 57 (2) , 220-232
Abstract
Jara‐Lazaro A R, Akhilesh M, Thike A A, Lui P C‐W, Tse G M‐K & Tan P H (2010) Histopathology 57, 220–232 Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms Aims: To establish histological and biological parameters that can predict phyllodes tumours on core biopsy specimens of indeterminate fibroepithelial neoplasms.Methods and results: Core biopsy specimens of fibroepithelial lesions diagnosed at the Department of Pathology, Singapore General Hospital from 2002 to 2007 were reviewed. Cases in which phyllodes tumour was favoured, or could not be ruled out, were evaluated for stromal cellularity/distribution, nuclear atypia and mitoses, stromal overgrowth, epithelial fronding, epithelial hyperplasia, configuration of lesional edge, presence of pseudoangiomatous stromal hyperplasia and of adipose tissue. Antibodies to Ki67, topoisomerase IIα, CD34, CD117 and Bcl‐2 were applied to sections subjected to immunohistochemistry using the streptavidin–biotin method. Findings were correlated with subsequent excisions. Of 261 core biopsy specimens of fibroepithelial lesions, 98 (37%) comprised cases in which phyllodes tumour could not be excluded and 57 (58%) had subsequent open surgical excisions. Marked stromal hypercellularity (5/5; 100%) and nuclear atypia (1/1; 100%), stromal overgrowth (17/17; 100%), mitoses ≥2/10 high‐power fields (18/18; 100%) and ill‐defined lesional borders (16/16 phyllodes tumours; 100%) were features in core biopsy specimens that exclusively predicted phyllodes tumour on excision. Moderate stromal hypercellularity (20/27 phyllodes tumours; 74%), stromal overgrowth, moderate nuclear atypia (14/16 phyllodes tumours; 87%), pseudoangiomatous stromal hyperplasia (19/23 phyllodes tumours; 83%) significantly correlated with their subsequent excisions. Immunohistochemical markers Ki67 ≥5% and topoisomerase IIα≥5%, and reduced or patchy CD34 on core biopsy specimens correlated significantly with a diagnosis of phyllodes.Conclusions: Stromal hypercellularity, combined with key histological features and immunohistochemical markers Ki67, topoisomerase IIα and CD34, reinforced by clinical findings, can predict phyllodes tumours on core biopsy specimens.Keywords
This publication has 18 references indexed in Scilit:
- Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumoursPathology, 2009
- A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra‐tumoral genetic heterogeneity and new genetic changes on recurrenceThe Journal of Pathology, 2008
- Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breastHistopathology, 2007
- Optimising preoperative diagnosis in phyllodes tumour of the breastJournal of Clinical Pathology, 2006
- p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray studyLaboratory Investigation, 2005
- Breast pathology practice: most common problems in a consultation serviceHistopathology, 2005
- Fibroepithelial Lesions With Cellular Stroma on Breast Core Needle BiopsyAmerican Journal of Clinical Pathology, 2005
- Phyllodes Tumors of the BreastAmerican Journal of Clinical Pathology, 2005
- Increased c-kit (CD117) expression in malignant mammary phyllodes tumorsLaboratory Investigation, 2004
- Nonmalignant Lesions in Breast Core Needle BiopsiesAmerican Journal of Surgical Pathology, 2002